September is Ovarian Cancer Awareness Month.
In women age 35-74, ovarian cancer is the fifth leading cause of cancer-related deaths. An estimated one woman in 58 will develop ovarian
cancer during her lifetime. The American Cancer Society estimates that there will be more than 22,000 new cases of ovarian cancer this year,
and more than 15,000 women will die from ovarian cancer annually.
The National Ovarian Cancer Coalition is dedicated to raising awareness and increasing education about ovarian cancer.
Established in 1995, the organization is committed to improving the survival rate and quality of life for women with this cancer.
More...
LifeScience Moment: The Hatch-Waxman Act was passed to encourage development of generic prescription drugs.
On Sept. 24, 1984 the Hatch-Waxman Act (Drug Price Competition and Patent Term Restoration Act) was passed to encourage development of
generic prescription drugs.
The Act, named for its sponsors, Representative Henry Waxman of California and Senator Orrin Hatch of Utah, established a process
whereby marketers of generic drugs can file Abbreviated New Drug Applications (ANDAs) to seek FDA approval of the generic; allows 180 day
exclusivity to companies that are the "first-to-file" an ANDA against holders of patents for branded counterparts; and streamlined the process
for approving generic drugs by requiring only that manufacturers demonstrate "bioequivalence" to an already approved innovator drug.
More...
Where do we come from?
Explore the genealogy of the life science industry by state or province through one-of-a-kind posters
illustrating the founding technology origins of life science companies.
More...
It's a Small World
|
| |
Ebola Virus (Photo: Courtesy Frederick Murphy)
| |
Science Quote
"A little knowledge is a dangerous thing. So is a lot."
| - |
Albert Einstein
|
|
(1879-1955)
|
